IRWD IRONWOOD PHARMACEUTICALS, INC.
Research report · from SEC EDGAR · close 2026-07-13
$4.21 -5.8%
$693.0M mkt cap
executive summary
IRONWOOD PHARMACEUTICALS, INC. (IRWD) is a $693.0M company. Revenue is $361.5M (+13.8% y/y) at a 28% net margin. It is profitable. Our health score is C (64/100). 2 red flags on file. It funds itself; low dilution risk.
Revenue (TTM)
$361.5M
+13.8% y/y
⛔Bankruptcy-risk zone
Altman Z-Score is in the distress zone (-3.61).
⚠One-sided insider selling
9 insider sales and no open-market buys in the recent window.
who's buying
Insider buys / sells
0 / 9
Cash & ST investments
$220.5M
Operating cash flow
$127.0M
Dilution shelf
active shelf
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-13 by stocktools.ai.